The effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers.

Trial Profile

The effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Mar 2012

At a glance

  • Drugs Hydroxyzine (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Apr 2011 Results published in the Journal of Clinical Psychopharmacology.
    • 19 Apr 2011 Status changed from recruiting to completed, based on results published in the Journal of Clinical Psychopharmacology.
    • 15 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top